Healthcare -
Biotechnology - NYSE - DK
$ 85.25
-0.105 %
$ 372 B
Market Cap
28.8
P/E
NVO - PRE-TAX INCOME
Pre-tax Income NVO - Novo Nordisk A/S
105 B
LAST VALUE
33.11%
2 YEAR CAGR
17.06%
5 YEAR CAGR
12.39%
10 YEAR CAGR